Liraglutide counteracts obesity and glucose intolerance in a mouse model of glucocorticoid-induced metabolic syndrome.

In fact, liraglutide reduced the induction of alpha-cell mass seen in corticosterone-treated mice, although this finding did not reach statistical significance.

also in 111,027 other papers